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Contribution and comparison of the wells score with the Geneva score and revised Geneva score for assessing pretest probability of pulmonary embolism in emergency department: Tunisian experience Salma Longo [Orateur] (1), Zied Frikha (2), H. Saidi (3), Elhabil Baha (4), Ihsen Zairi (5), Sofien Kammoun (6), Sana Fennira (5), N Falfoul (3), Z Jerbi (3), Sondos Kraim (7) (1) Hôpital Habib Thameur, Cardiologie, Tunis, Hôpitaux de Tunis, Cardiologie, Sfax, Urgences, Tunis, Hôpitaux de Tunis, Tunis, Tunis, Hôpitaux de Tunis, Tunis, Cardiologie, Tunis, Tunisie Introduction: In recent years, clinical assessment of pretest probability has become a crucial tool in the diagnostic approach of patients with suspected pulmonary embolism (PE). Study objective Study and compare the predictive accuracy of clinical prediction scores: the Wells score(WS) with the Geneva score(GS) and revised Geneva score(RGS) in the assessment of pretest probability of PE Methods: It is a monocentric, retrospective study concerning 150 patients having diagnosed with deep venous thrombosis(DVT) hospitalized in the emergency department during the period from January 1997 to December 2008.
Results:
The study population consisted of 150 patients diagnosed with DVT confirmed by lower limb ultrasonographic examination. A total of 34 ( 23 %)) patients were diagnosed with PE. The distribution of the patients according to the groups and the under groups in the three clinical prediction scores as well as the frequency of PE are summarized in this table below The comparison of the predictive accuracy of the SW and the SG showed an area under the ROC curve of 0,889 for the SW and 0,834 for the SG with a slight superiority of the score of wells. the concordance between these two scores was moderated (u =0,58 ). The SGR had an inferior concordance compared to the SW (u =0,4 ) and SG (u =0,278 ) Purpose: High aldosterone levels are associated with vascular injury and poor outcome after STEMI. We hypothesized that early aldosterone receptor blockade at admission for primary PCI may improve myocardial perfusion.
Methods: 159 consecutive patients admitted for primary PCI for STEMI were treated by 200 mg IV potassium canrenoate at presentation. The patients were randomly matched to 318 patients based on the admission GRACE score's deciles. Myocardial blush grade (MBG) was assessed in all patients by 2 operators blinded to the treatment. The outcome of the study was the rate of MBG 3 after primary PCI. A multivariable conditional logistic regression model adjusted on abciximab and thienopyridine pre-treatment, and the symptom to needle time was used to compare cases and controls.
Results: cases and controls were comparable regarding age (63±14 vs 62±14) gender (mal 81 vs 79%), and baseline risk factors. Cases presented later (7.7±9.5 vs 5.6±5.4, p=NS) and were less often treated by abciximab (75 vs 84%, p<0.05).
TIMI flow grades prior and after primary PCI were comparable between cases and controls. Based on TIMI flow grade the success rate was comparable between cases and controls (87 vs 90%). MBG 3 rate was significantly higher in cases than in controls with an adjusted OR 2.23 (95%CI 1.40-3.55). included in its registry. We assessed the INTERMACS (IMCS) classification in patients admitted in an ICU with cardiogenic shock. Methods: Consecutive patients with cardiogenic shock on admission who were admitted in a tertiary hospital ICU. IMCS status was assessed at within the first 24 hours and 96 hours after admission. Outcomes (bi-ventricular assist device (BiVAD), heart transplantation (HT) and mortality) were recorded in hospital and at 3 and 12 months.
Results: The study included 87 patients (median age 60 [IQR:54-69] years). 41 (47%) patients had IABP and 27 (31%) were on mechanical ventilation. At 24 hours after admission, 7 patients (8.04%) with IMCS Profile 1 (critical cardiogenic shock), 18 (20.6%) with IMCS Profile 2 (sliding on inotropes) and 62 (71.3%) with IMCS Profile 3 (dependant on inotropes). Results are presented in the table.
Conclusion: In patients with cardiogenic shock, the INTERMACS classification is an easy way to classify patient's risk during the first 24 hours. Evolution of IMCS profiles allows to assess response to treatment over time. It may present as a useful tool in the ICU to discuss early the best strategies to manage cardiogenic shocks. The use of drugs is the subject of numerous recommendations. Most of sudden cardiac deaths (SD) are related to a ventricular fibrillation (VF) and ischemic heart disease, but some of them are drug-related. The purpose of study was to evaluate the prevalence of drug-related SD's and the possible changes during these past 20 years.
Methods: 239 patients, 181 men, 58 women, aged from 12 to 88 years (61±15) were admitted after SD resuscitation outside the acute phase of myocardial infarction, 139 before 2000 (group I), 100 between 2000 and 2010 (group II). Clinical data, treatment, electrolytes, echocardiography, Holter ECG, exercise testing, electrophysiological study (EPS), evaluation of coronary status and ergonovine test when coronary arteries were normal, were collected.
The causes of resuscitated SD's did not change significantly during these 2 periods. The presence or not of heart disease (HD) did not differ: 34 group I patients (24%) and 34 group II patients (34%) had no apparent (HD)(NS). Ischemic HD, idiopathic dilated cardiomyopathy, valvular HD, coronary spasm, various HD's, preexcitation syndrome or ion channel disorders were as frequent in group I (42%, 11.5%, 12%, 3%, 3.5%, 4%) as in group II (34%, 11%, 6%, 4%, 6%, 5%). Drug-related SD's did not change during these periods: 38 patients presented a drug-related VT/VF or asystole with cardiac arrest, 20 (14%) before 2000 and 18 patients (18%) since 2000. SD was caused by hypokaliema or increase of QT interval or a major conduction disturbance. HD or abnormal ECG was present in 20 patients. Digoxin, diuretics, calcium inhibitors, betablockers, antiarrhythmic drugs alone or in association were the implicated drugs.
Conclusion: Drug-related arrhythmias continue to explain at least 15% of SD's. Despite the publication of numerous recommendations on the use of drugs, the number of fatal events that may be attributed to a cardiovascular drug did not decrease between the years before 2000 and after 2000. 
We enrolled 31 consecutive patients (mean age 33±15 years, 74% men). Electrocution was due to domestic current (alternating current, 230V singlephase, 50Hz of frequency) in 65% of cases. Electrocution was a work related accident in 70% of cases. Superficial burns were observed in 87% of patients. Cardiac troponin Ic level (normal range <0.04 μg/ml) was found to be elevated in 16% of patients (mean 0,09±0,03 μg/ml) and creatinine kinase level was found to be increased in 55% of patients (426±713 UI/l). Electrocardiogram abnormalities were noticed in 84% of cases (ventricular hypertrophy in 11, incomplete bundle branch block in 9, diffuse ST-segment elevation in 6, and negative T waves in inferolateral leads in 13). Echocardiography was performed in 6% of patients and revealed mild septal hypertrophy (mean 13±2 mm) without segmental wallmotion abnormalities. During a mean ICU stay of 1±0.5 day, none of the patients presented atrial or ventricular arrythmias nor sudden death. During a mean followup of 30±10 months, 29% of patients were lost and the remaining 71% did not present physical or psychological sequelae related to electrocution.
Conclusion:
In our study, the initial course of all electrocuted patients was uneventful. These results suggest that systematic hospitalization in ICU may not be mandatory after electrocution.
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